Zhejiang AngLiKang Pharmaceutical CO.,LTD.
002940.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.69B
Close$
$15.34
36% downside
Current Fair Value
36% downsideOvervalued by 36% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.69 Billion |
|---|---|
| Enterprise Value | $4.99 Billion |
| Dividend Yield | $0.25 (1.04%) |
| Earnings per Share | $0.62 |
| Beta | 0.75 |
| Outstanding Shares | 196,108,486 |
Return
| Return on Equity | 6.92% |
|---|---|
| Return on Assets | 3.85% |
| Return on Invested Capital | 7.25% |
Valuation & Multiples
| P/E Ratio | 41.28 |
|---|---|
| PEG | -161.96 |
| Price to Sales | 3.99 |
| Price to Book Ratio | 2.66 |
| Enterprise Value to Revenue | 3.76 |
| Enterprise Value to EBIT | 31.25 |
| Enterprise Value to Net Income | 43 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang AngLiKang Pharmaceutical CO.,LTD.
1,236 employees
CEO: Guo Gang Zheng Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on the manufacturing and distribution of various pharmaceutical goods. Their operations span the production and sale of active pharmaceutical ingredients (APIs), f...